glp 1 fda approved for weight loss New GLP-1 Pill Foundayo (Orforglipron) Gets Approval Obesity FDA-approved GLP-1 pill offers cheaper,

January 22, 2026: Gastroparesis Lawsuits Progressing While a lot of attention in recent months has been devoted to the emerging vision loss litigation, gastroparesis lawsuits involving Ozempic and other GLP-1s are still progressing

This is uncommon, and it mainly applies to those with existing diabetes related eye conditions rather than people without a history of them

The pharmacology is different enough that CagriSema results cannot be assumed to transfer to a tirzepatide pairing

AOD9604 and Cartilage Biology Research In a collagenase-induced knee osteoarthritis rabbit model, intra-articular injection of AOD9604 significantly enhanced cartilage regeneration compared to saline controls, with combined AOD9604 and hyaluronic acid injections proving more effective than either treatment alone producing superior morphological and histopathological scores and a significantly shorter lameness period in the AOD9604 + HA group